Associations between N-terminal procollagen type III, tissue inhibitors of matrix metalloproteinase and atrial fibrillation in patients with mitral stenosis

The N-terminal procollagen types III (PIIINP) play an important role in triggering the remodeling process. In fact, the relationship between PIIINP and atrial fibrillation (AF) in patient mitral valve diseases is unresolved. This study aimed to assess relationships among serum PIIINP and atrial fibrillation remodeling in patients with mitral stenosis. One hundred and seventeen patients MS were screened for AF (51 without AF and 66 with AF) in the cardiology department of La Rabta Hospital. Plasma levels of PIIINP and TIMP-1-2 were measured by ELISA sandwich assay. Multiple linear regression analysis by the backward method was used. PIIINP ( P = 0.013), TIMP-1 ( P = 0.033) and TIMP-2 ( P = 0.049) were significantly lower in patients with AF compared to patients without AF. The serum levels of the following biomarkers protected the occurrence of AF according of ROC curves analysis: PIIINP (AUC = 0.625; 95% CI: 0.509–0.742; P = 0.039; cut-off =236.7 pg/mL; sensitivity (Se) 60%, specificity (Sp) 66%) and TIMP-1 (AUC = 0.631 (95% CI 0.514–0.748); P = 0.033; cut-off = 36.8 ng/mL; Se 75%, Sp 60%). The correlation analysis showed that PIIINP significantly negatively correlated with end-diastolic volume (EDV) ( r = −0,353; P = 0.05) and with the mitral valve area ( r = −0,338; P = 0.048). TIMP-1 correlated positively Wilkins score ( r = 0,432; P = 0.015) and PIIINP ( r = 0,229; P = 0.021). In patients without AF, no correlation is found between these biomarkers and clinical parameters. Multiple linear regression analysis by the backward method was used for detection of significant biomarkers that influenced the occurrence of AF. In fact, the PIIINP ( P = 0.047) and TIMP1 ( P = 0.030) have a significant negative effect on occurrence of AF. Our findings to suggest that significant decrease in plasma levels of PIIINP may be an indication of AF in patients with mitral stenosis.

Authors

Institutions

Publication Details

Journal
Archives of cardiovascular diseases
Published
2026-01-01
DOI
https://doi.org/10.1016/j.acvd.2025.10.157
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations between N-terminal procollagen type III, tissue inhibitors of matrix metalloproteinase and atrial fibrillation in patients with mitral stenosis

S. Aloui, Rachid Mechmèche, Mounia Allal-Elasmi, Amira Zaroui et al.
Archives of cardiovascular diseases
Cardiac Valve Diseases and Treatments
article

Associations between N-terminal procollagen type III, tissue inhibitors of matrix metalloproteinase and atrial fibrillation in patients with mitral stenosis

S. Aloui, Rachid Mechmèche, Mounia Allal-Elasmi, Amira Zaroui, H. Sanhaji, M.-S. Mourali, W. Zidi, S. Ouali
article en

Abstract

The N-terminal procollagen types III (PIIINP) play an important role in triggering the remodeling process. In fact, the relationship between PIIINP and atrial fibrillation (AF) in patient mitral valve diseases is unresolved. This study aimed to assess relationships among serum PIIINP and atrial fibrillation remodeling in patients with mitral stenosis. One hundred and seventeen patients MS were screened for AF (51 without AF and 66 with AF) in the cardiology department of La Rabta Hospital. Plasma levels of PIIINP and TIMP-1-2 were measured by ELISA sandwich assay. Multiple linear regression analysis by the backward method was used. PIIINP ( P = 0.013), TIMP-1 ( P = 0.033) and TIMP-2 ( P = 0.049) were significantly lower in patients with AF compared to patients without AF. The serum levels of the following biomarkers protected the occurrence of AF according of ROC curves analysis: PIIINP (AUC = 0.625; 95% CI: 0.509–0.742; P = 0.039; cut-off =236.7 pg/mL; sensitivity (Se) 60%, specificity (Sp) 66%) and TIMP-1 (AUC = 0.631 (95% CI 0.514–0.748); P = 0.033; cut-off = 36.8 ng/mL; Se 75%, Sp 60%). The correlation analysis showed that PIIINP significantly negatively correlated with end-diastolic volume (EDV) ( r = −0,353; P = 0.05) and with the mitral valve area ( r = −0,338; P = 0.048). TIMP-1 correlated positively Wilkins score ( r = 0,432; P = 0.015) and PIIINP ( r = 0,229; P = 0.021). In patients without AF, no correlation is found between these biomarkers and clinical parameters. Multiple linear regression analysis by the backward method was used for detection of significant biomarkers that influenced the occurrence of AF. In fact, the PIIINP ( P = 0.047) and TIMP1 ( P = 0.030) have a significant negative effect on occurrence of AF. Our findings to suggest that significant decrease in plasma levels of PIIINP may be an indication of AF in patients with mitral stenosis.

Archives of cardiovascular diseasesVol. 119(1)
Hôpital La Rabta (TN)
Good health and well-being
Openalex Percentile: Top 95%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.